Less obvious is the potential
harm of false positive results and subsequent costly or invasive procedures.
Not exact matches
Specifically, the task force says the «
harms and costs
of false -
positive results, over diagnosis and overtreatment» outweigh any «significant reductions in the relative risk
of death from breast cancer.»
They suggest most women in their 40s should not have routine mammograms because the tests may cause more
harm than good because
of false positive results (follow - up testing proves negative for cancer).
Given the lack
of mortality benefit
of screening, and the moderate to substantial
harms that could
result from
false -
positive screeningtest
results and subsequent surgery, the USPSTF concludes with moderate certainty that the
harms of screening for ovarian cancer outweigh the benefit, and the net balance
of the benefit and
harms of screening is negative.